GURE:NASDAQGulf Resources, Inc. Analysis
Data as of 2026-06-19 - not real-time
$3.85
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Technical outlook: GURE trades at $3.85, well below its 20‑day (4.26), 50‑day (4.31) and 200‑day (4.87) SMAs, with a bearish MACD histogram and a neutral‑to‑slightly‑oversold RSI at 45. Volume is decreasing and 30‑day volatility exceeds 100%, indicating a fragile price environment. Valuation signals are mixed: the price‑to‑book ratio of 0.05 and price‑to‑sales of 0.29 suggest deep discounting, while the DCF fair value of $89.3 implies extreme undervaluation, a gap likely driven by the company’s distressed fundamentals.
Fundamental and risk backdrop: The firm reports negative gross (‑28%) and operating margins, a trailing EPS of –$49.34 and a debt‑to‑equity of 7.5, flagging solvency concerns. Cash of $5.8 M is insufficient to cover $8.1 M debt, and free cash flow is strongly negative. A recent Nasdaq notice over a delayed quarterly filing adds regulatory risk, and the China‑centric operations heighten geographic exposure. Combined with a low beta (~0.1) but high volatility and thin trading, the overall risk profile is elevated.
Fundamental and risk backdrop: The firm reports negative gross (‑28%) and operating margins, a trailing EPS of –$49.34 and a debt‑to‑equity of 7.5, flagging solvency concerns. Cash of $5.8 M is insufficient to cover $8.1 M debt, and free cash flow is strongly negative. A recent Nasdaq notice over a delayed quarterly filing adds regulatory risk, and the China‑centric operations heighten geographic exposure. Combined with a low beta (~0.1) but high volatility and thin trading, the overall risk profile is elevated.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Bearish technical indicators (price below all SMAs, negative MACD)
- Negative margins and high debt burden
- Regulatory uncertainty from Nasdaq filing delay
Medium Term
1–3 yearsCautious
Model confidence: 6/10
Key Factors
- Continued cash flow deficits and unsustainable leverage
- High price volatility and decreasing trading volume
- Lack of clear turnaround catalyst
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Potential for deep value if restructuring succeeds
- Strategic position in bromine and crude salt markets
- Uncertainty around future earnings and debt resolution
Key Metrics & Analysis
Financial Health
Revenue Growth303.40%
Profit Margin-286.76%
ROE-43.38%
ROA-4.60%
Debt/Equity7.50
P/B Ratio0.0
Op. Cash Flow$5.5M
Free Cash Flow$-12061764
Technical Analysis
TrendBearish
RSI45.2
Support$3.51
Resistance$5.40
MA 20$4.25
MA 50$4.31
MA 200$4.87
MACDBearish
VolumeDecreasing
Fear & Greed Index92.14
Valuation
Fair Value$89.31
GradeUndervalued
TypeValue
Risk Assessment
Beta0.11
Volatility107.10%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.